NSN 6505-00-059-9019 of Chlordiazepoxide Hydrochloride C - Parts Details
| Alternative NSN: 6505000599019 |
| Item Name: Chlordiazepoxide Hydrochloride C |
| FSG: 65 Medical Dental and Veterinary Equipment and Supplies |
| Federal Supply Class (FSC): 6505 Drugs and Biologicals |
| NIIN: 000599019 |
| NCB Code: USA (00) |
| Manufacturers: Watson Labs Inc , Generics Bidco I Llc , Barr Laboratories Inc , Rugby Group Inc , Hoffmannla Roche Inc , Novartis Pharmaceuticals Ltd |
ASAP Aviation Procurement, owned and operated by ASAP Semiconductor, is the latest parts procurement platform for the aerospace and aviation industry. Check out high demanding part numbers NDC52544-0787-05, NDC00603-2668-28, NDC00591-0787-05, NDC00555-0159-04, NDC00536-3489-05 under NSN 6505-00-059-9019 of Chlordiazepoxide Hydrochloride C manufactured by Watson Labs Inc, Generics Bidco I Llc, Barr Laboratories Inc, Rugby Group Inc, Hoffmannla Roche Inc.
Federal Supply Class of NSN 6505-00-059-9019 is FSC 6505 contains part details of Drugs and Biologicals. Quote for your desired part numbers.
Part Number's List for NSN 6505-00-059-9019, 6505000599019
-
Part No Manufacturer Item Name QTY RFQ NDC52544-0787-05 Watson Labs Inc chlordiazepoxide hydrochloride c Avl RFQ NDC00603-2668-28 Generics Bidco I Llc chlordiazepoxide hydrochloride c Avl RFQ NDC00591-0787-05 Watson Labs Inc chlordiazepoxide hydrochloride c Avl RFQ NDC00555-0159-04 Barr Laboratories Inc chlordiazepoxide hydrochloride c Avl RFQ NDC00536-3489-05 Rugby Group Inc chlordiazepoxide hydrochloride c Avl RFQ NDC00140-0003-14 Hoffmannla Roche Inc chlordiazepoxide hydrochloride c Avl RFQ NDC00078-2084-05 Novartis Pharmaceuticals Ltd chlordiazepoxide hydrochloride c Avl RFQ 76222 Hoffmannla Roche Inc chlordiazepoxide hydrochloride c Avl RFQ
Characteristics Data of NSN 6505000599019MRC Criteria Characteristic AJCN PROTECTIVE STORAGE FEATURE SECURITY STORAGE AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 25.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AKJC CAPSULE TYPE HARD CQCT PRIMARY CONTAINER TYPE BOTTLE CQLS CAPSULE CONTENT FORM POWDER CXCY III PART NAME ASSIGNED BY CONTROLLING AGENCY CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES USP 25MG 500S CYLZ CAPSULE PRIMARY CONTAINER CONTENT QUANTITY 500.000 FEAT SPECIAL FEATURES GREEN CAP,WHITE BASE MDES MEDICAL DESIGNATION AND GRADE UNITED STATES PHARMACOPEIA
| MRC | Criteria | Characteristic |
|---|---|---|
| AJCN | PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 25.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT |
| AKJC | CAPSULE TYPE | HARD |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CQLS | CAPSULE CONTENT FORM | POWDER |
| CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES USP 25MG 500S |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 500.000 |
| FEAT | SPECIAL FEATURES | GREEN CAP,WHITE BASE |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |